DCW234, also known as butyl 4-(butyryloxy)benzoate, is a synthetic nonsteroidal estrogen and a selective agonist of the ERò. It shows modest selectivity in terms of affinity and transactivation for the ERò over the ERñ. Its affinity for the ERò was 3.43 üM and for the ERñ was 22.5 üM, while it activated the ERò and ERñ with EC<sub>50</sub> values of 1.71âÂÂ2.5 üM and 19.8âÂÂ22.5 üM, respectively. As such, its binding selectivity for the ERò over the ERñ was 7-fold and its functional selectivity for the ERò over the ERñ was between 10- and 13-fold.